This complicates the scenario in postmenopausal women since the reduction of estrogens with the concomitant increase in androgens leads to downregulation of TRPV5 channel expression contributing to osteoporosis by affecting bone homeostasis and Ca2+ reabsorption. The gene discussed is TRPV5; the disease is osteoporosis.